Condition: Atrial Fibrillation · Hemostasis · Sponsor: Kansas City Heart Rhythm Research Foundation
The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
This description comes directly from the study's public registry record.
Donita Atkins · 816-651-1969 · Datkins@kchrf.com
Always discuss trial participation with your own doctor first.
| Kansas City Heart Rhythm Institute - Roe Clinic | Overland Park, Kansas, United States | Recruiting |
| Overland Park Regional Medical Center | Overland Park, Kansas, United States | Recruiting |
| Centerpoint Medical Center Clinic | Independence, Missouri, United States | Recruiting |
| Centerpoint Medical Center | Independence, Missouri, United States | Recruiting |
| Research Medical Center Clinic | Kansas City, Missouri, United States | Recruiting |
| Research Medical Center | Kansas City, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06078735